Head injuries and concussions are a hot topic among athletes, coaches and the sport community. BrainScope’s Ahead 300, a handheld point of care device that objectively and rapidly assesses mild head injury, is helping clinicians and others to gather data that will aid in head injury diagnosis. BrainScope announced this month that it is doing a limited launch to a select group that includes college and professional sports institutions.
The Ahead 300, which was cleared by the FDA last September, uses a disposable electrode sensor headset, signal processing, algorithms and machine learning to analyze the patient’s data. Generally, the Ahead 300 works to analyze patients with symptoms present that could indicate everything from structural brain injury to mild traumatic brain injury including concussions.